Accession Number : ADA524250
Title : Project BioShield: Authorities, Appropriations, Acquisitions, and Issues for Congress
Descriptive Note : Congressional rept.
Corporate Author : LIBRARY OF CONGRESS WASHINGTON DC CONGRESSIONAL RESEARCH SERVICE
Personal Author(s) : Gottron, Frank
Report Date : 02 JUL 2010
Pagination or Media Count : 18
Abstract : Many potential chemical, biological, radiological, and nuclear (CBRN) terrorism agents lack available medical countermeasures. In 2003, President Bush proposed Project BioShield to address this need. The Project BioShield Act became law in July 2004 (P.L. 108-276). This law has three main provisions: (1) relaxing regulatory requirements for some CBRN terrorism-related spending, including hiring personnel and awarding research grants; (2) guaranteeing a federal government market for new CBRN medical countermeasures; and (3) permitting emergency use of unapproved countermeasures. The Department of Health and Human Services (HHS) has used each of these authorities. The HHS used expedited review authorities to approve contracts and grants related to CBRN countermeasure research and development. The HHS used the authority to guarantee a government market to obligate approximately $2 billion to acquire countermeasures against anthrax, botulism, radiation, and smallpox. The HHS has also employed the emergency use authority several times, including allowing young children with H1N1 "swine" influenza to receive specific antiviral drugs.
Descriptors : *TERRORISM , *RADIOLOGICAL WARFARE AGENTS , *CHEMICAL WARFARE AGENTS , *BIOLOGICAL WARFARE AGENTS , *NUCLEAR WARFARE , DRUGS , ANTIVIRAL AGENTS , ANTHRAX , COUNTERMEASURES , CHILDREN , BOTULISM , MEDICINE , ACQUISITION , EMERGENCIES , UNITED STATES GOVERNMENT , VARIOLA VIRUS , CONGRESS
Subject Categories : CIVIL DEFENSE
CHEMICAL, BIOLOGICAL AND RADIOLOGICAL WARFARE
Distribution Statement : APPROVED FOR PUBLIC RELEASE